Proposed metrics to benchmark antibiotic prescribing in pediatric outpatient settings

Nicole M Poole1, Bethany A Wattles2, Rana E El Feghaly3

  • 1Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO.

Insights

Developing standardized metrics for pediatric outpatient antibiotic prescribing is crucial for improving antibiotic stewardship and preventing overuse. These high-priority measures will enable national benchmarking and targeted interventions.

Area of Science:

  • Pediatric infectious disease
  • Antimicrobial stewardship
  • Health services research

Background:

  • Antibiotic overuse in pediatric outpatient settings contributes to resistance and adverse events.
  • Current methods for tracking pediatric antibiotic prescribing lack standardization and national comparability.
  • Effective metrics are essential for monitoring and improving antibiotic utilization.

Purpose of the Study:

  • To identify and propose high-priority metrics for electronic reporting of outpatient pediatric antibiotic use.
  • To facilitate national benchmarking and monitoring of pediatric antibiotic prescribing patterns.
  • To support the development of targeted interventions for antimicrobial stewardship.

Main Methods:

  • Review and evaluation of existing metrics for outpatient pediatric antibiotic prescribing.
  • Assessment of the impact and feasibility of various proposed metrics.
  • Selection of high-priority measures suitable for electronic reporting.

Main Results:

  • Identification of key metrics for tracking pediatric outpatient antibiotic prescribing.
  • Proposal of a streamlined set of measures for electronic reporting.
  • Establishment of a foundation for national data collection and analysis.

Conclusions:

  • Standardized metrics are vital for effective antimicrobial stewardship in pediatric outpatient care.
  • Electronic reporting of select high-priority measures will enable national monitoring and improvement efforts.
  • Implementation of these metrics can guide targeted interventions to optimize antibiotic use and mitigate risks.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
41
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
52
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
42
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
36
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
47
Antibiotic Selection00:57

Antibiotic Selection

Overview
56.7K